| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022474 |
| Receipt No. | R000024508 |
| Official scientific title of the study | Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2016/05/26 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer | |
| Title of the study (Brief title) | Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer | |
| Region |
|
|
| Condition | |||
| Condition | blood cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Intervention method of the rehabilitation to prevemt a physical strength decline to the patient who piled up chemotherapy by blood cancer is considered. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Utilization on a lehabilitation brochure and support according to the state of the patient lead to effective rehabilitation intervention from the hospitalization time as well as the rehabilitation added to treatment coolness. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Receiving chemotherapy after hospitalization since 2015 to the blood tumor internal medicine of the hospital patients who particpated in any of the intervention of rehabilitation due to physical therapists rehabilitation or ward by rehabilitation brochure gymnastics. | |||
| Key exclusion criteria | No. | |||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Erika Konishi |
| Organization | Shikoku Cancer Center |
| Division name | Nurs |
| Address | Ehime Matsuyama minamiumemoto 160 |
| TEL | 089-999-1111 |
| erkonishi@shikoku-cc.go.jp | |
| Public contact | |
| Name of contact person | Erika Konishi |
| Organization | Shikoku Cancer Center |
| Division name | Nurs |
| Address | Ehime Matsuyama minamiumemoto 160 |
| TEL | 0899991111 |
| Homepage URL | |
| erkonishi@shikoku-cc.go.jp | |
| Sponsor | |
| Institute | Shikoku Cancer Center |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | No. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 四国がんセンター(愛媛県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Words and deeds of the subject to the question of researchers. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024508 |